# Medical and Surgical Hybrid Treatment of Atrial Fibrillation.

> **NCT02630914** · NA · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 12 (actual)

## Conditions studied

- Atrial Fibrillation (AF)

## Interventions

- **DEVICE:** The AtriCure Synergy Ablation System

## Key facts

- **NCT ID:** NCT02630914
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2018-03
- **Final completion:** 2018-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02630914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02630914, "Medical and Surgical Hybrid Treatment of Atrial Fibrillation.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02630914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*